Planned enrollment increased by 60 participants
Before: 510 participants (planned). After: 570 participants (planned).
Study sponsor: Immuneering Corporation
Primary completion is the date data collection ends for the main study measures, not when results are published.
Before: 510 participants (planned). After: 570 participants (planned).